tiprankstipranks
Trending News
More News >
Keros Therapeutics (KROS)
NASDAQ:KROS
US Market

Keros Therapeutics (KROS) Technical Analysis

Compare
342 Followers

Technical Sentiment

Overall Consensus
Sell
6Bullish
5Neutral
11Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Sell
3Bullish
0Neutral
9Bearish
Keros Therapeutics’s (KROS) Moving Averages Convergence Divergence (MACD) indicator is -0.16, suggesting Keros Therapeutics is a Buy.
Keros Therapeutics’s (KROS) 20-Day exponential moving average is 13.67, while Keros Therapeutics’s (KROS) share price is $13.45, making it a Sell.
Keros Therapeutics’s (KROS) 50-Day exponential moving average is 13.78, while Keros Therapeutics’s (KROS) share price is $13.45, making it a Sell.

Keros Therapeutics (KROS) Pivot Points

Jul 08, 2025, 04:22 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
12.65
12.94
13.18
13.47
13.71
14.00
14.24
Fibonacci
12.94
13.15
13.27
13.47
13.68
13.80
14.00
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Keros Therapeutics (KROS) Moving Averages

Jul 08, 2025, 04:22 PM
Period
Simple
Exponential
MA5
13.41Buy
13.44Buy
MA10
13.52Sell
13.51Sell
MA20
13.74Sell
13.67Sell
MA50
14.03Sell
13.78Sell
MA100
12.64Buy
15.99Sell
MA200
27.59Sell
27.53Sell
Keros Therapeutics’s (KROS) 10-Day exponential moving average is 13.51, while Keros Therapeutics’s (KROS) share price is $13.45, making it a Sell.
Keros Therapeutics’s (KROS) 100-Day exponential moving average is 15.99, while Keros Therapeutics’s (KROS) share price is $13.45, making it a Sell.
Keros Therapeutics’s (KROS) stock price is $13.45 and Keros Therapeutics’s (KROS) 50-day simple moving average is 14.03, creating a Sell signal.
Keros Therapeutics’s (KROS) stock price is $13.45 and Keros Therapeutics’s (KROS) 100-day simple moving average is 12.64, creating a Buy signal.
Keros Therapeutics’s (KROS) stock price is $13.45 and Keros Therapeutics’s (KROS) 200-day simple moving average is 27.59, creating a Sell signal.

Keros Therapeutics (KROS) Technical Indicators

Jul 08, 2025, 04:22 PM
Name
Value
Implied Action
RSI (14)
43.39
Neutral
STOCH (9,6)
20.94
Neutral
STOCHRSI (14)
20.60
Neutral
MACD (12,26)
-0.16
Buy
ADX (14)
18.41
Buy
Williams %R
-72.00
Buy
CCI (14)
-56.33
Neutral
ATR (14)
0.45
-
Ultimate Oscillator
35.27
Neutral
ROC
-1.39
Sell
Keros Therapeutics’s (KROS) Relative Strength Index (RSI) is 43.39, creating a Neutral signal.
Keros Therapeutics’s (KROS) Trend Strength Indicator (ADX) is 18.41, creating a Buy signal.
Keros Therapeutics’s (KROS) Commodity Channel Index (CCI) is -56.33, creating a Neutral signal.
Keros Therapeutics’s (KROS) Price Rate of Change (ROC) is -1.39, creating a Sell signal.

FAQ

Is KROS a Buy, Hold, or Sell?
Based on KROS’s technical indicators, KROS is a Sell.
    What is KROS’s RSI (14)?
    KROS’s RSI (14) is 43.39, which suggests KROS is a Neutral.
      What is KROS’s MACD?
      KROS’s MACD is -0.16, which suggests KROS is a Buy.
        What is KROS’s 5-day moving average?
        KROS’s 5-day moving average is 13.41, which suggests KROS is a Buy.
          What is KROS’s 20-day moving average?
          KROS 20-day moving average is 13.74, which suggests KROS is a Sell.
            What is KROS’s 50-day moving average?
            KROS’s 50-day moving average is 14.03, which suggests KROS is a Sell.
              What is KROS’s 200-day moving average?
              KROS’s 200-day moving average is 27.59, which suggests KROS is a Sell.
                What is KROS’s Williams % R (14)?
                KROS’s Williams % R (14) is -72.00, which suggests KROS is a Buy.
                  What is KROS’s CCI (14)?
                  KROS’s CCI (14) is -56.33, which suggests KROS is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis